Antibodies of CSE1L


2 antibodies are included.     

 Released    NotSatisfied    Submitted    NotReviewed    OnHold    Submitting    Experimented   
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
CSE1LProduct_ID: A300-472A
Lot_ID: 2
Source: Bethyl Labs
Target Name: CSE1L-human		 Bethyl_A300-472A_2_CSE1L.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the CSE1L specific antibody, A300-472A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the CSE1L-specific antibody, A300-472A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.
 CSE1L-K562-CRISPR-A300-472A.png<br>Caption: Western blot following CRISPR against CSE1L in K562 whole cell lysate using CSE1L specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CSE1L. CSE1L protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.
CSE1LProduct_ID: A300-473A
Lot_ID: 2
Source: Bethyl Labs
Target Name: CSE1L-human		 CSE1L-HEPG2-CRISPR-A300-473A.png<br>Caption: Western blot following CRISPR against CSE1L in HepG2 whole cell lysate using CSE1L specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CSE1L. CSE1L protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.
 Bethyl_A300-473A_2_CSE1L.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the CSE1L specific antibody, A300-473A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the CSE1L-specific antibody, A300-473A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.
 CSE1L-K562-CRISPR-A300-473A.png<br>Caption: Western blot following CRISPR against CSE1L in K562 whole cell lysate using CSE1L specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CSE1L. CSE1L protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.